No. | Title | Date | View |
---|---|---|---|
49 | 2023-03-27 | 13 | |
48 | 2022-11-28 | 719 | |
47 |
OliX Announces Positive Preclinical Data in NASH Non-human Primate Models
|
2022-11-10 | 515 |
46 |
OliX Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for AMD
|
2022-08-08 | 1121 |
45 | 2022-07-05 | 1056 | |
44 | 2022-07-05 | 882 | |
43 | 2022-06-13 | 943 | |
42 | 2022-06-07 | 1076 | |
41 | 2022-05-27 | 1761 | |
40 | 2022-05-27 | 885 | |
39 | 2022-04-12 | 1333 | |
38 |
OliX Pharmaceuticals to Participate in BIO-Europe Spring®
|
2022-03-24 | 1226 |
37 | 2022-03-22 | 1439 | |
36 |
OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference
|
2022-03-22 | 1109 |
35 | 2022-03-22 | 938 | |
34 |
OliX Pharmaceuticals Subsidiary mCureX Strengthens Scientific Advisory Board
|
2022-03-22 | 884 |
33 | 2022-03-22 | 884 | |
32 |
OliX Pharmaceuticals Enters Agreement with Pharmaron
|
2022-03-22 | 970 |
31 |
Hansoh Pharma and OliX Pharmaceuticals Enter into Licensing and Collaboration Agreement
|
2021-10-19 | 3056 |
30 | 2021-08-17 | 3846 |
- Home
- PR